Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemiaAlexander E Perl, Margaret T Kasner, Donald E Tsai, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
Cancer Cell|August 18, 2012
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repressionOmar Abdel-Wahab, Mazhar Adli, Lindsay M LaFave, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Mapping the Cellular Biogeography of Human Bone Marrow Niches Using Single-Cell Transcriptomics and Proteomic ImagingShovik Bandyopadhyay, Michael Duffy, Kyung Jin Ahn, et al.
Pageof 13